$RIGL News Article - National Comprehensive Cancer Network Adds Newly Approved REZLIDHIA(TM) (olutasidenib) to Clinical Practice Guidelines in Oncology for Acute Myeloid Leukemia https://marketwirenews.com/news-releases/nati...56363.html
(0)
(0)
Rigel Pharmaceuticals Inc. (RIGL) Stock Research Links